TrialBMC nephrology2012

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.

Anatole Besarab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.